Cargando…

Phylogenomic Analysis of Human Papillomavirus Type 31 and Cervical Carcinogenesis: A Study of 2093 Viral Genomes

Human papillomavirus (HPV) type 31 (HPV31) is closely related to the most carcinogenic type, HPV16, but only accounts for 4% of cervical cancer cases worldwide. Viral genetic and epigenetic variations have been associated with carcinogenesis for other high-risk HPV types, but little is known about H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinheiro, Maisa, Harari, Ariana, Schiffman, Mark, Clifford, Gary M., Chen, Zigui, Yeager, Meredith, Cullen, Michael, Boland, Joseph F., Raine-Bennett, Tina, Steinberg, Mia, Bass, Sara, Xiao, Yanzi, Tenet, Vanessa, Yu, Kai, Zhu, Bin, Burdett, Laurie, Turan, Sevilay, Lorey, Thomas, Castle, Philip E., Wentzensen, Nicolas, Burk, Robert D., Mirabello, Lisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540939/ https://www.ncbi.nlm.nih.gov/pubmed/34696378 http://dx.doi.org/10.3390/v13101948

Ejemplares similares

Human papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: Whole viral genome sequences from 7116 HPV16-positive women()
por: Clifford, Gary M., et al.
Publicado: (2019)

Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance
por: Zhu, Bin, et al.
Publicado: (2020)

The Intersection of HPV Epidemiology, Genomics and Mechanistic Studies of HPV-Mediated Carcinogenesis
por: Mirabello, Lisa, et al.
Publicado: (2018)

Genetic and Epigenetic Variations of HPV52 in Cervical Precancer
por: Bee, Katharine J., et al.
Publicado: (2021)

Deep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection
por: Cullen, Michael, et al.
Publicado: (2015)

HPV16 E7 Nucleotide Variants Found in Cancer-Free Subjects Affect E7 Protein Expression and Transformation
por: Lou, Hong, et al.
Publicado: (2022)

Viral coinfection analysis using a MinHash toolkit
por: Dawson, Eric T., et al.
Publicado: (2019)

The Cervical Microbiome over 7 Years and a Comparison of Methodologies for Its Characterization
por: Smith, Benjamin C., et al.
Publicado: (2012)

PB2093: DIFFUSE LARGE B CELL LYMPHOMA IN THE ELDERLY
por: Abichou, G., et al.
Publicado: (2022)

Therapeutic effect of the gastrin receptor antagonist, CR2093 on gastrointestinal tumour cell growth.
por: Watson, S. A., et al.
Publicado: (1992)

APOBEC Mutagenesis Is Concordant between Tumor and Viral Genomes in HPV-Positive Head and Neck Squamous Cell Carcinoma
por: Faden, Daniel L., et al.
Publicado: (2021)

TuberOus SClerosis registry to increase disease Awareness (TOSCA) – baseline data on 2093 patients
por: Kingswood, John C., et al.
Publicado: (2017)

2093: Utilization of an ICD-coded electronic health records (EHR) database to characterize the epidemiology of prosopagnosia
por: Pressl, Christina, et al.
Publicado: (2018)

2093. Prescribing of Antibiotics by Provider Type Across the Veterans Health Administration (VHA), 2015–2017
por: Suda, Katie J, et al.
Publicado: (2019)

PB2093: OVERALL SURVIVAL IN RELAPSED-REFRACTORY MYELOMA PATIENTS DEPENDS ON CIRCULATING PLASMA CELLS QUANTITATION
por: Parrinello, Nunziatina Laura, et al.
Publicado: (2023)

Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes
por: Wagner, Sarah, et al.
Publicado: (2019)

Safety evaluation of the food enzyme catalase from the non‐genetically modified Aspergillus niger strain CTS 2093
por: Lambré, Claude, et al.
Publicado: (2023)

Low Risk of Cervical Cancer/Precancer Among Most Women Under Surveillance Postcolposcopy
por: Demarco, Maria, et al.
Publicado: (2018)

2093. Utilizing Implementation Science to Identify Barriers and Facilitators to Implementing Harm Reduction Services in the Veterans Health Administration (VHA)
por: Harvey, Leah, et al.
Publicado: (2022)

Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines
por: Demarco, Maria, et al.
Publicado: (2017)

A Study of Partial Human Papillomavirus Genotyping in Support of the 2019 ASCCP Risk-Based Management Consensus Guidelines
por: Demarco, Maria, et al.
Publicado: (2020)

PReS-FINAL-2093: Can clinical response within 12 weeks in JIA-etanercept receivers predict the future clinical remission?
por: Pratsidou-Gertsi, P, et al.
Publicado: (2013)

2093. Chlorhexidine Gluconate Bathing to Prevent Central Line Associated Infections: What to Do When the Patient Can Bathe Themselves
por: Bleasdale, Susan C, et al.
Publicado: (2018)

Genome-Wide Association Study of 2,093 Cases With Idiopathic Polyneuropathy and 445,256 Controls Identifies First Susceptibility Loci
por: Winsvold, Bendik S., et al.
Publicado: (2021)

The Improving Risk Informed HPV Screening (IRIS) Study: Design and Baseline Characteristics
por: Gage, Julia C., et al.
Publicado: (2022)

Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting
por: Landy, Rebecca, et al.
Publicado: (2019)

Issues in optimising and standardising the accuracy and utility of the colposcopic examination in the HPV era
por: Schiffman, Mark, et al.
Publicado: (2015)

Cervical Screening Performance
por: Schiffman, Mark, et al.
Publicado: (2021)

Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program
por: Wentzensen, Nicolas, et al.
Publicado: (2019)

A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs
por: Demarco, Maria, et al.
Publicado: (2020)

Distinguishing Genetic Drift from Selection in Papillomavirus Evolution
por: Burk, Robert D., et al.
Publicado: (2023)

Pangenome and Phylogenomic Analysis of the Pathogenic Actinobacterium Rhodococcus equi
por: Anastasi, Elisa, et al.
Publicado: (2016)

A population-based cross-sectional study of age-specific risk factors for high risk human papillomavirus prevalence in rural Nigeria
por: Clarke, Megan A, et al.
Publicado: (2011)

Phylogenomic analyses data of the avian phylogenomics project
por: Jarvis, Erich D, et al.
Publicado: (2015)

Redesign of a rapid, low‐cost HPV typing assay to support risk‐based cervical screening and management
por: Desai, Kanan T., et al.
Publicado: (2022)

Characterization of population-based variation and putative functional elements for the multiple-cancer susceptibility loci at 5p15.33
por: Mirabello, Lisa, et al.
Publicado: (2014)

Niche adaptation and viral transmission of human papillomaviruses from archaic hominins to modern humans
por: Chen, Zigui, et al.
Publicado: (2018)

Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines
por: Egemen, Didem, et al.
Publicado: (2020)

Accuracy and Efficiency of Deep-Learning–Based Automation of Dual Stain Cytology in Cervical Cancer Screening
por: Wentzensen, Nicolas, et al.
Publicado: (2020)

An Introduction to the 2019 ASCCP Risk-Based Management Consensus Guidelines
por: Schiffman, Mark, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vjmop8lnmnajbmqrvgitrdlerf